AI Score

Unlock

AI Score

Our AI model analyzes fundamental, technical, and statistical indicators to predict the probability of a bullish trend over the next three months.

We regularly update and refine our models to deliver the most reliable forecasts for you.

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

OraSure Technologies Inc. (OSUR)

AI Score

Unlock

AI Score

Bullish Probability	Sentiment	Score
+80%	Strong Buy	10
+75%	Buy	9
+70%	Buy	8
+60%	Buy	7
+50%	Hold	6
+45%	Hold	5
+40%	Hold	4
+35%	Sell	3
+30%	Sell	2
+20%	Strong Sell	1

3.88

-0.06 (-1.52%)

At close: Feb 20, 2025, 3:59 PM

3.88

-0.13%

After-hours: Feb 20, 2025, 04:00 PM EST

undefined% (undefined)

Bid	3.75
Market Cap	289.80M
Revenue (ttm)	-
Net Income (ttm)	-
EPS (ttm)	0.15
PE Ratio (ttm)	25.9
Forward PE	n/a
Analyst	Hold

Ask	4.05
Volume	600,257
Avg. Volume (20D)	878,093
Open	3.92
Previous Close	3.94
Day's Range	3.85 - 3.93
52-Week Range	3.52 - 8.04
Beta	undefined

About OSUR

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test...

[Show more]

Industry Medical - Instruments & Supplies

Sector Healthcare

IPO Date Nov 17, 1986

Employees 638

Stock Exchange NASDAQ

Ticker Symbol OSUR

Website https://www.orasure.com

Full Company Profile

Analyst Forecast

According to 2 analyst ratings, the average rating for OSUR stock is "Hold." The 12-month stock price forecast is $5.5, which is an increase of 41.57% from the latest price.

Buy 0.00%

Hold 100.00%

Sell 0.00%

Stock Forecasts

Next Earnings Release

OraSure Technologies Inc. is scheduled to release its earnings on Feb 25, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription

Why Price Moved

6 months ago

-8.06%

OraSure Technologies shares are trading lower afte... Unlock content with Pro Subscription

News

3 weeks ago · zacks.com

OraSure (OSUR) Upgraded to Strong Buy: What Does It Mean for the Stock?

OraSure (OSUR) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

3 weeks ago · zacks.com

New Strong Buy Stocks for January 27th

ALNY, HBT, APH, GNTY and OSUR have been added to the Zacks Rank #1 (Strong Buy) List on January 27, 2024.

4 weeks ago · zacks.com

Should Value Investors Buy OraSure Technologies (OSUR) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

1 month ago · zacks.com

New Strong Buy Stocks for January 16th

MRCY, BBCP, OSUR, VIK and IFS have been added to the Zacks Rank #1 (Strong Buy) List on January 16, 2025.

1 month ago · zacks.com

Are Investors Undervaluing OraSure Technologies (OSUR) Right Now?

1 month ago · zacks.com

OSUR Stock Rises Following the Acquisition of Sherlock Biosciences

OraSure announces acquisition of Sherlock Biosciences to strengthen its molecular diagnostics portfolio.

2 months ago · seekingalpha.com

OraSure Technologies: Discounted Assets With An Attractive Free Call Option

OraSure Technologies is undervalued, trading below its net current asset value, offering a compelling risk-reward scenario with limited downside risk. The company has a robust balance sheet with no lo...

2 months ago · zacks.com

Is OraSure Technologies (OSUR) Stock Undervalued Right Now?